CV Sciences Investor Relations Material
Latest events
Q4 2023
CV Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from CV Sciences Inc
Access all reports
CV Sciences, Inc. operates as a life science company in North America. The Consumer Products segment engages in manufacturing, marketing, and selling nutraceutical products to wholesale distributors, retailers, and directly to consumers through e-commerce sites. The Specialty Pharmaceutical segment provides commercial and clinical supply of pharmaceutical grade cannabinoids for use in research, therapeutic trials, and for prescription drug formulations.
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States